Gunderson Dettmer represented BillionToOne on the deal. BillionToOne, a next-generation molecular diagnostics company, announced the $125 million Series C financing co-led by Adams Street Partners and Hummingbird...
BillionToOne’s $125 Million Series C Financing
Theseus Pharmaceuticals’ $160 Million IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer...